TuHURA Biosciences/$HURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TuHURA Biosciences
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
Ticker
$HURA
Sector
Primary listing
Employees
19
Headquarters
Website
HURA Metrics
BasicAdvanced
$114M
-
-$0.66
-
-
Price and volume
Market cap
$114M
52-week high
$4.44
52-week low
$0.41
Average daily volume
2.2M
Financial strength
Current ratio
0.397
Quick ratio
0.353
Long term debt to equity
0.507
Total debt to equity
4.211
Interest coverage (TTM)
-47.12%
Profitability
EBITDA (TTM)
-25.351
Management effectiveness
Return on assets (TTM)
-60.16%
Return on equity (TTM)
-418.06%
Valuation
Price to book
5.84
Price to tangible book (TTM)
32.72
Price to free cash flow (TTM)
-3.358
Free cash flow yield (TTM)
-29.78%
Free cash flow per share (TTM)
-0.56
Growth
Earnings per share change (TTM)
161.08%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for TuHURA Biosciences stock?
TuHURA Biosciences (HURA) has a market cap of $114M as of March 20, 2026.
What is the P/E ratio for TuHURA Biosciences stock?
The price to earnings (P/E) ratio for TuHURA Biosciences (HURA) stock is 0 as of March 20, 2026.
Does TuHURA Biosciences stock pay dividends?
No, TuHURA Biosciences (HURA) stock does not pay dividends to its shareholders as of March 20, 2026.
When is the next TuHURA Biosciences dividend payment date?
TuHURA Biosciences (HURA) stock does not pay dividends to its shareholders.
What is the beta indicator for TuHURA Biosciences?
TuHURA Biosciences (HURA) does not currently have a Beta indicator.